These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Removal of regulations regarding certification of antibiotic drugs--FDA. Direct final rule. Fed Regist; 1998 May 12; 63(91):26066-9. PubMed ID: 10179333 [Abstract] [Full Text] [Related]
5. Investigational new drug applications; clinical holds--FDA. Direct final rule. Fed Regist; 1998 Dec 14; 63(239):68676-8. PubMed ID: 10187558 [Abstract] [Full Text] [Related]
8. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule. Fed Regist; 1998 Sep 29; 63(188):51825-7. PubMed ID: 10185812 [Abstract] [Full Text] [Related]
9. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule. Fed Regist; 1998 Apr 27; 63(80 Pt 1):20530-3. PubMed ID: 10179319 [Abstract] [Full Text] [Related]
12. Investigational new drug applications; clinical holds; companion document to direct final rule--FDA. Proposed rule. Fed Regist; 1998 Dec 14; 63(239):68710-2. PubMed ID: 10187560 [Abstract] [Full Text] [Related]
18. Administrative practices and procedures; internal agency review of decisions; companion document to direct final rule--FDA. Proposed rule. Fed Regist; 1998 Jun 16; 63(115):32772-4. PubMed ID: 10180279 [Abstract] [Full Text] [Related]
19. Quality mammography standards. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule. Fed Regist; 1999 Jun 17; 64(116):32404-7. PubMed ID: 10558582 [Abstract] [Full Text] [Related]